Fei Yu
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- Viral gastroenteritis research and epidemiology
- Virology top 2%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 22
- SARS-CoV-2 and COVID-19 Research 13
- Epidemiology 32
- Influenza Virus Research Studies 15
- Herpesvirus Infections and Treatments 7
- Respiratory viral infections research 7
- Co-authors
- Shibo Jiang (50 shared papers)Lanying Du (11 shared papers)Lu Lu (31 shared papers)Ruiying Liang (12 shared papers)Chungen Pan (2 shared papers)David M. Ojcius (1 shared paper)Xiaoqian Deng (7 shared papers)Lili Wang (8 shared papers)
- Journals
- Microbes and Infection (5 papers)Journal of Virology (3 papers)Journal of Medicinal Chemistry (3 papers)AIDS (3 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Fei Yu
78 papers receiving 2.9k citations
Fei Yu's Hit Papers
Peers
Comparison fields: 5 of 133
- Infectious Diseases 1.6k
- Virology 377
- Epidemiology 835
- Animal Science and Zoology 252
- Hepatology 154
Countries citing papers authored by Fei Yu
This map shows the geographic impact of Fei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Yu more than expected).
Fields of papers citing papers by Fei Yu
This network shows the impact of papers produced by Fei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Yu. The network helps show where Fei Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent advances in the detection of respiratory virus infection in humans Hit paper breakdown → | 2020 | 403 |
| 2 | Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor Hit paper breakdown → | 2014 | 327 |
| 3 | 2020 | 275 | |
| 4 | 2013 | 133 | |
| 5 | 2017 | 121 | |
| 6 | 2013 | 114 | |
| 7 | 1998 | 111 | |
| 8 | 1997 | 92 | |
| 9 | 2012 | 91 | |
| 10 | 2013 | 91 | |
| 11 | 2020 | 82 | |
| 12 | 2021 | 60 | |
| 13 | 2015 | 58 | |
| 14 | 2018 | 49 | |
| 15 | 2013 | 45 | |
| 16 | 2020 | 42 | |
| 17 | 2014 | 41 | |
| 18 | 2019 | 40 | |
| 19 | 2014 | 39 | |
| 20 | 2015 | 34 |
About Fei Yu
Fei Yu is a scholar working on Infectious Diseases, Epidemiology, Virology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 85 papers that have together received 3.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (31 papers), HIV/AIDS drug development and treatment (22 papers), Influenza Virus Research Studies (15 papers), SARS-CoV-2 and COVID-19 Research (13 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Herpesvirus Infections and Treatments (7 papers), Hepatitis C virus research (7 papers) and Respiratory viral infections research (7 papers). The work is most often cited by research in Infectious Diseases (1.6k citations), Virology (377 citations), Epidemiology (835 citations), Animal Science and Zoology (252 citations) and Hepatology (154 citations). Fei Yu has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Shibo Jiang, Lanying Du, Lu Lu, Ruiying Liang, Chungen Pan, David M. Ojcius, Xiaoqian Deng, Lili Wang, Meng Su and Naru Zhang. Their work appears in journals such as Microbes and Infection, Journal of Virology, Journal of Medicinal Chemistry, AIDS and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.